CBS 2019
CBSMD教育中心
English

肺动脉高压

科研文章

荐读文献

Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Pulmonary Hypertension Caused by a Coconut Left Atrium Chronic thromboembolic pulmonary hypertension Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial Sotatercept for the Treatment of Pulmonary Arterial Hypertension Transthoracic echocardiography for the evaluation of children and adolescents with suspected or confirmed pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and D6PK Left main coronary artery compression in pulmonary hypertension Factors associated with pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study

Clinical TrialAvailable online 7 April 2021

JOURNAL:JACC: Heart Failure Article Link

Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial

D Burkhoff, BA Borlaug, SJ Shah et al. Keywords: PH-HFpEF; pulmonary capillary wedge pressure; 6MWD

Full Text PDF